Molecular Profiling to Predict Response to Treatment

**Semantic type:** Conceptual Entity

**Definition:** An initiative supporting the retrospective characterization and analysis of biospecimens collected from NCI-sponsored trials. Its objectives are to: 1. perform next-generation sequencing on archived tumor and normal biospecimens collected from patients enrolled on completed clinical trials with available outcome data and 2. analyze the molecular characterization and clinical data following hypotheses developed by teams of clinicians and scientists associated with the NCI-sponsored trials.

**Synonyms:** - MP2PRT - MP2PRT